MarketFriction

Biogen Pharmachem Industries Ltd

BSE 531752 · Other Financial Services
₹0.27 -3.57%
BSE close2026-10-01
Market cap₹28.4 Cr.

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales0.000.000.78-0.090.000.001.350.000.000.540.580.44
Expenses0.040.030.040.070.350.540.170.200.390.080.940.22
Operating Profit-0.04-0.030.74-0.16-0.35-0.541.18-0.20-0.390.46-0.360.22
OPM %94.87%87.41%85.19%-62.07%50.00%
Other Income0.760.090.000.00-0.650.230.001.54-0.100.000.000.00
Interest0.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax0.720.060.74-0.16-1.00-0.311.181.34-0.490.46-0.360.22
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit0.720.060.74-0.16-1.00-0.311.181.34-0.490.46-0.360.22
EPS in Rs0.010.000.01-0.00-0.01-0.000.020.01-0.000.00-0.000.00
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales0.000.000.110.950.001.622.470.002.381.202.551.56
Expenses0.030.126.720.950.123.222.490.450.451.491.601.63
Operating Profit-0.03-0.12-6.610.00-0.12-1.60-0.02-0.451.93-0.290.95-0.07
OPM %-6,009.09%0.00%-98.77%-0.81%81.09%-24.17%37.25%-4.49%
Other Income0.000.000.050.000.000.000.010.910.000.000.01-0.10
Interest0.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax-0.03-0.12-6.560.00-0.12-1.60-0.010.461.93-0.290.96-0.17
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%10.42%
Net Profit-0.03-0.12-6.560.00-0.12-1.60-0.010.461.93-0.290.86-0.17
EPS in Rs-0.00-0.00-0.090.00-0.00-0.02-0.000.010.03-0.000.010.00
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%10%%16%
Compounded Profit Growth41%20%85%-114%
Stock Price CAGR3%-12%-26%-62%
Return on Equity-1%1%1%1%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital65.2665.2665.2665.2665.2665.2665.2665.2665.2665.2665.2690.26
Reserves-4.27-4.30-4.42-10.98-10.99-9.51-11.12-11.13-10.67-8.7426.678.83
Borrowings10.006.210.720.010.630.310.000.000.000.000.000.00
Other Liabilities2.491.641.691.642.730.030.110.820.240.300.090.31
Total Liabilities73.4868.8163.2555.9357.6356.0954.2554.9554.8356.8292.0299.40
Fixed Assets0.000.000.000.000.000.000.000.000.000.000.000.00
CWIP0.000.000.000.000.000.000.000.000.000.000.000.00
Investments43.7826.6922.393.526.256.459.496.958.855.4423.8432.78
Other Assets29.7042.1240.8652.4151.3849.6444.7648.0045.9851.3868.1866.62
Total Assets73.4868.8163.2555.9357.6356.0954.2554.9554.8356.8292.0299.40
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-7.284.68-0.07-13.650.09-1.213.951.401.701.94-1.081.57
Cash from Investing Activity17.0817.084.3014.32-0.721.54-3.64-1.32-1.66-2.06-32.62-9.56
Cash from Financing Activity-11.19-21.74-4.31-0.710.62-0.32-0.310.000.000.0035.706.30
Net Cash Flow-1.380.02-0.07-0.03-0.020.000.000.080.05-0.112.00-1.69
Free Cash Flow-7.284.68-0.07-13.650.09-1.213.951.401.701.94-1.081.57
CFO/OP18,200%-15,600%58%207%1,008%-247%-7,000%-378%101%372%176%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days23,326.823,085.21572.280.000.000.000.00
Inventory Days0.000.000.00
Days Payable
Cash Conversion Cycle23,326.823,085.21572.280.000.000.000.00
Working Capital Days23,194.092,651.05549.75152.21-35.27170.33-20.04
ROCE %-0.15%-0.04%-0.19%-11.32%0.00%-0.22%-2.90%-0.02%-0.37%3.47%-0.39%1.01%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Public100.00%100.00%100.00%100.00%99.99%100.00%99.99%100.00%100.00%100.00%99.99%100.00%
No. of Shareholders1,97,8261,97,8321,97,7571,97,7952,80,6003,03,7803,02,3622,98,7032,93,3272,89,9872,89,1552,93,626

Fundamentals

Market Cap₹ 28.4 Cr.
Current Price₹ 0.27
Book Value₹ 0.94
ROCE1.01 %
ROE0.90 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)16%
Compounded Profit Growth (TTM)-114%
Standalone figures.
Valuation
Market capRs 24 Cr
Enterprise valueRs 24 Cr
Price to book0.25x
Price to sales9.56x
EV / sales9.43x
Price to cash flow15.52x
Earnings yield-0.70%
P/E, 3-year average38.48x
P/B, 3-year average0.68x
P/E, 5-year average49.77x
P/B, 5-year average0.82x
Profitability
Operating margin (excl. other income)37.25%
Operating margin (incl. other income)37.65%
EBITDA margin-6.67%
Pre-tax margin-6.67%
Net profit margin-6.67%
Net margin, latest quarter50.00%
ROE0.90%
ROCE1.01%
ROA0.90%
ROE, 3-year average1.33%
ROCE, 3-year average1.36%
ROA, 3-year average1.32%
ROE, 5-year average0.96%
ROCE, 5-year average0.98%
ROA, 5-year average0.96%
ROIC (approx.)-0.15%
Tax rate10.42%
Other income / net worth0.01%
Growth
Sales growth (latest year)112.50%
Sales CAGR, 5 years9.50%
Profit CAGR, 3 years23.19%
Sales growth QoQ-24.14%
Profit growth YoY (latest quarter)-83.58%
Per share
EPS (TTM)Rs -0.00
EPS (latest year)Rs 0.01
EPS (latest quarter)Rs 0.00
EPS, 3-year averageRs 0.01
EPS, 5-year averageRs 0.01
Book value per shareRs 1.10
Sales per shareRs 0.03
Cash flow per shareRs 0.02
Free cash flow per shareRs 0.02
Efficiency
Asset turnover0.03x
Cash conversion cycle0 days
Working capital days-20 days
Leverage
Cash and bankRs 0 Cr
Net debtRs -0 Cr
Owners' fund to total sources99.69%
Cash flow
Cash from Operating Activity (latest year)Rs 2 Cr
Cash from Investing Activity (latest year)Rs -10 Cr
Cash from Financing Activity (latest year)Rs 6 Cr
Net Cash Flow (latest year)Rs -2 Cr
Free cash flow (latest year)Rs 2 Cr
Cash from ops / profit, 5 years1.87x
Sales to cash flow1.62x
Statement figures
Net sales (TTM)Rs 3 Cr
Net sales (latest year)Rs 3 Cr
Sales (latest quarter)Rs 0 Cr
Operating profit excl. other income (latest year)Rs 1 Cr
Operating profit (latest quarter)Rs 0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -0 Cr
PBDT (TTM)Rs -0 Cr
Profit before tax (TTM)Rs -0 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs -0 Cr
Net profit (latest year)Rs 1 Cr
Net profit (latest quarter)Rs 0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total expenditure (latest year)Rs 2 Cr
Total income (latest year)Rs 3 Cr
Share capitalRs 90 Cr
ReservesRs 9 Cr
Shareholders' fundsRs 99 Cr
Total assetsRs 99 Cr
InvestmentsRs 33 Cr
Other liabilitiesRs 0 Cr
Shares outstanding (crore)90.26
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 0.25 is at the 2th percentile (median 0.61).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period531752Nifty 50Difference
1 week-3.6%-2.8% -0.8 pts
1 month-3.6%-6.8% +3.2 pts
3 months-12.9%-7.6% -5.3 pts
3 years-60.9%+14.2% -75.0 pts
5 years-47.1%+27.9% -75.0 pts

Red flags

F-score 7 of 8
explainShare dilution Share count up 38% in a year, 38% in three
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹0 Cr. Net profit ₹0 Cr -83.6%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
CRISIL Ltd32,64636.932.6 %
RRP Semiconductor Ltd11,182-32.7 %
Onemi Technology Solutions Ltd6,35920.122.7 %
Asset Reconstruction Company (India) Ltd4,64013.214.0 %
Colab Platforms Ltd2,62254222.4 %
Algoquant Fintech Ltd1,85741.531.4 %
GYFTR Ltd1,19854.96.77 %
Prime Securities Ltd1,03360.68.25 %
Centrum Capital Ltd9967.33 %
Wealth First Portfolio Managers Ltd94928.734.6 %
RNFI Services Ltd79227.927.3 %
Stellant Securities (India) Ltd53014.571.7 %
The Investment Trust of India Ltd47314.58.54 %
Akiko Global Services Ltd46724.237.3 %
Regency Fincorp Ltd41524.010.5 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Biogen Pharmachem Industries Ltd?

Biogen Pharmachem Industries Ltd (531752) has a market capitalisation of Rs 28.4 Cr. at the 2026-10-01 close.

What were Biogen Pharmachem Industries Ltd's latest quarterly results?

In the Jun 2026 quarter, Biogen Pharmachem Industries Ltd sales was Rs 0 Cr and net profit was Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03